Bioxyne Limited (AU:BXN) has released an update.
Bioxyne Limited, an Australian life sciences company, has announced an investor webinar hosted by Managing Director Sam Watson to discuss company updates and answer questions. The online event is scheduled for September 25, 2024, and will include a Q&A session where participants can learn more about Bioxyne’s global pharmaceutical and consumer health products. Registration for the webinar is open, with details available upon sign-up.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.